当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析 - 现金流量表

国药一致

(000028)

  

流通市值:117.31亿  总市值:136.58亿
流通股本:4.78亿   总股本:5.57亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金79,383,613,590.3656,070,519,821.7437,138,131,730.8316,287,280,704.3
收到的税费返还7,735,047.127,333,548.34,394,851.24411,185.81
收到其他与经营活动有关的现金1,017,351,924.13548,142,791.98349,499,524.04127,498,855.21
经营活动现金流入的平衡项目0000
经营活动现金流入小计80,408,700,561.6156,625,996,162.0237,492,026,106.1116,415,190,745.32
购买商品、接受劳务支付的现金69,771,420,769.4449,894,816,260.9532,848,602,917.115,227,092,389.07
支付给职工以及为职工支付的现金3,488,147,660.182,674,232,305.271,869,263,752.25990,608,027.35
支付的各项税费1,779,197,158.421,354,888,198.4948,439,053.91473,685,561.93
支付其他与经营活动有关的现金2,098,466,676.541,420,967,289.31896,342,874.07357,950,535.87
经营活动现金流出的平衡项目0000
经营活动现金流出小计77,137,232,264.5855,344,904,053.9336,562,648,597.3317,049,336,514.22
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额3,271,468,297.031,281,092,108.09929,377,508.78-634,145,768.9
二、投资活动产生的现金流量:
收回投资收到的现金20,614,176.9620,614,176.9616,060,380.3816,060,380.38
取得投资收益收到的现金187,595,964.62187,595,964.6225,409,794.358,695,574.15
处置固定资产、无形资产和其他长期资产收回的现金净额1,197,954.34744,371.41238,528.8786,316.42
收到的其他与投资活动有关的现金8,034,149.278,034,149.274,884,814.32-
投资活动现金流入的平衡项目0000
投资活动现金流入小计217,442,245.19216,988,662.2646,593,517.9224,842,270.95
购建固定资产、无形资产和其他长期资产支付的现金282,695,594.62203,338,759.36139,171,544.1971,904,876.18
投资支付的现金14,032,26013,482,2605,429,3604,924,360
取得子公司及其他营业单位支付的现金71,400,00071,400,00071,400,000-
投资活动现金流出的平衡项目0000
投资活动现金流出小计368,127,854.62288,221,019.36216,000,904.1976,829,236.18
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-150,685,609.43-71,232,357.1-169,407,386.27-51,986,965.23
三、筹资活动产生的现金流量:
吸收投资收到的现金2,000,0002,000,0002,000,000-
其中:子公司吸收少数股东投资收到的现金2,000,0002,000,0002,000,000-
取得借款收到的现金1,560,135,333.4986,511,176.5777,490,495.31557,824,459.29
收到其他与筹资活动有关的现金262,104,595.31422,241,981.18485,490,847.47433,787,208.83
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,824,239,928.711,410,753,157.681,264,981,342.78991,611,668.12
偿还债务支付的现金1,575,149,262.991,158,578,369.7899,425,920.93485,354,763.71
分配股利、利润或偿付利息支付的现金671,211,382.94592,161,511.07506,017,372.5564,659,820.82
其中:子公司支付给少数股东的股利、利润67,445,717.4742,672,810.6622,477,357.665,147,085.18
支付其他与筹资活动有关的现金1,409,115,430.81,646,236,678.21906,326,346.67322,557,089.66
筹资活动现金流出平衡项目0000
筹资活动现金流出小计3,655,476,076.733,396,976,558.982,311,769,640.15872,571,674.19
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,831,236,148.02-1,986,223,401.3-1,046,788,297.37119,039,993.93
四、汇率变动对现金及现金等价物的影响-1,196,465.06-1,200,190.66-1,224,255.92,810.99
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,288,350,074.52-777,563,840.97-288,042,430.76-567,089,929.21
加:期初现金及现金等价物余额5,835,294,456.355,835,294,456.355,835,294,456.355,835,294,456.35
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额7,123,644,530.875,057,730,615.385,547,252,025.595,268,204,527.14
补充资料:
净利润237,003,526.49-770,054,628.11-
资产减值准备994,531,638.52-37,101,805.55-
固定资产和投资性房地产折旧1,478,078,694-91,058,865.45-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,478,078,694-91,058,865.45-
无形资产摊销67,270,966.46-34,247,093.69-
长期待摊费用摊销198,395,234.03-81,480,370.72-
处置固定资产、无形资产和其他长期资产的损失-11,871,648.1--4,032,827.99-
固定资产报废损失1,916,115.87-118,912.39-
公允价值变动损失20,675,083.9--3,149,334.95-
财务费用258,301,906.01-131,085,697.1-
投资损失-379,677,806.48--215,396,248.05-
递延所得税-55,228,181.02--21,995,925.19-
其中:递延所得税资产减少-23,679,443.18--15,565,610.13-
递延所得税负债增加-31,548,737.84--6,430,315.06-
存货的减少559,597,921.71--400,847,107.65-
经营性应收项目的减少-965,326,601.2--3,651,680,554.77-
经营性应付项目的增加463,053,069.7-3,316,133,743.13-
其他305,422,559.01-105,893,240.2-
不涉及现金收支的投资和筹资活动金额其他项目1,086,088,548.98---
现金的期末余额7,123,644,530.87-5,547,252,025.59-
减:现金的期初余额5,835,294,456.35-5,835,294,456.35-
公告日期2025-04-082024-10-292024-08-292024-04-26
审计意见(境内)标准无保留意见
TOP↑